Title : Cost-analysis of relapsing-remitting multiple sclerosis in Italy after the introduction of new disease-modifying agents.

Pub. Date : 2004

PMID : 17516727






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND AND OBJECTIVE: During the last decade, several agents have proven to be effective in the treatment of relapsing-remitting multiple sclerosis (RRMS), for example interferon-beta (IFNbeta) and glatiramer acetate. Glatiramer Acetate interferon beta 1 Homo sapiens
2 BACKGROUND AND OBJECTIVE: During the last decade, several agents have proven to be effective in the treatment of relapsing-remitting multiple sclerosis (RRMS), for example interferon-beta (IFNbeta) and glatiramer acetate. Glatiramer Acetate interferon beta 1 Homo sapiens